Tumor thickness in mesothelioma predicts differential response to neoadjuvant therapy and survival.

The Journal of thoracic and cardiovascular surgery(2022)

引用 1|浏览5
暂无评分
摘要
We present the first study demonstrating the relationship between baseline tumor thickness and differential radiographic response to neoadjuvant therapy and survival. Further studies are needed to validate tumor thickness as both a prognostic and predictive biomarker.
更多
查看译文
关键词
RECIST,chemotherapy,mesothelioma,neoadjuvant,surgery,tumor thickness
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要